Phenaris Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Phenaris General Information
Description
Developer of computational drug design technology designed to provide data, models and decision support in all aspects of in silico toxicology. The company specializes in offering multiple alternatives to transporter informatics, safety assessment and modeling of binding kinetics, enabling toxicologists to gain support in medicinal chemistry.
Contact Information
Website
www.phenaris.comCorporate Office
- Maria-Jacobi-Gasse 1
- Media Quarter Marx
- Vienna, 1030
- Austria
Corporate Office
- Maria-Jacobi-Gasse 1
- Media Quarter Marx
- Vienna, 1030
- Austria
Phenaris Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 07-Sep-2024 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | 01-Sep-2020 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
Phenaris Signals
Phenaris FAQs
-
When was Phenaris founded?
Phenaris was founded in 2018.
-
Where is Phenaris headquartered?
Phenaris is headquartered in Vienna, Austria.
-
What is the size of Phenaris?
Phenaris has 4 total employees.
-
What industry is Phenaris in?
Phenaris’s primary industry is Biotechnology.
-
Is Phenaris a private or public company?
Phenaris is a Private company.
-
What is Phenaris’s current revenue?
The current revenue for Phenaris is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process